Skip to main content
Log in

Differences in tolerance to mescaline produced by peripheral and direct central administration

  • Original Investigations
  • Animal Studies
  • Published:
Psychopharmacologia Aims and scope Submit manuscript

Abstract

A fixed-ratio schedule of food reinforcement (FR 30) was used to study the differences in tolerance produced by peripheral injections and intraventricular infusions of mescaline hydrochloride in rats. Successive daily administrations of 10 mg mescaline/kg i.p. resulted in a decrease in behavioral disruption (tolerance). The following day, intraventricular infusion of a dose of mescaline previously shown to be approximately equal to the peripheral dose in terms of behavioral disruption was started. After tolerance to central administration of mescaline was established, 10 mg/kg of mescaline injected i.p. resulted in behavioral disruption equal to that produced by the first i.p. injection.

In a second experiment, blood pressure effects of mescaline given i.p. and intraventricularly were studied. Peripherally administered mescaline produced marked effects on caudally measured blood pressure and increased biting upon and struggling within the restraining device. Mescaline administered centrally did not appear to elicit similar cardiovascular changes. These data suggest that different mechanisms may be involved in the formation of tolerance to mescaline administered by these two routes as measured by means of a fixed ratio reinforcement schedule.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Appel, J., Freedman, D.: Tolerance and cross-tolerance among psychomimetic drugs. Psychopharmacologia (Berl.) 13, 267–274 (1968).

    Google Scholar 

  • Baldestrieri, A., Fontanari, D.: Acquired and crossed tolerance to mescaline, LSD-25 and BOL-148. Arch. gen. Psychiat. 1, 279–282 (1959).

    Google Scholar 

  • Bebbington, A., Brimblecombe, R.: Actions of some toxic substances (psychomimetics) on the central nervous system. Brit. med. Bull. 25, 293–298 (1969).

    Google Scholar 

  • Cerletti, A., Rothlin, E.: Role of 5-hydroxytryptamine in mental diseases and its antagonism to lysergic acid derivatives. Nature (Lond.) 176, 785–786 (1955).

    Google Scholar 

  • Feldberg, W.: The action of drugs injected into the cerebral ventricles. In: S. Garattini and V. Ghetti, Eds.: Psychotropic drugs. Amsterdam: Elsevier 1957.

    Google Scholar 

  • Freedman, D., Aghajanian, G., Ornitz, E., Rosner, B.: Patterns of tolerance to lysergic acid diethylamide and mescaline in rats. Science 127, 1173–1174 (1958).

    Google Scholar 

  • Greenblatt, E., Osterberg, A.: Correlations of activating and lethal effects of excitatory drugs in grouped and isolated mice. J. Pharmacol. exp. Ther. 131, 115–119 (1961).

    Google Scholar 

  • Haley, T.: Pharmacological actions from intracerebral drug injections. In: S. Garattini and V. Ghetti, Eds.: Psychotropic drugs. Amsterdam: Elsevier (1957).

    Google Scholar 

  • Isbell, H., Miner, E., Logan, C.: Relationship of psychomimetic to antiserotonin potencies of congeners of lysergic acid diethylamide (LSD-25). Psychopharmacologia (Berl.) 1, 20–28 (1959).

    Google Scholar 

  • Jarvik, M., Abramson, H., Hirsch, M.: Comparative subjective effects of seven drugs including lysergic acid diethylamide (LSD-25). J. abnorm. soc. Psychol. 51, 657–676 (1967).

    Google Scholar 

  • Noble, E., Wurtman, R., Axelrod, J.: A simple and rapid method for injecting H3-norepinephrine into the lateral ventricle of the rat brain. Life Sci. 6, 281–291 (1967).

    Google Scholar 

  • Robinson, R., Cutler, W., Lorenzo, A., Barlow, C.: Transport of sulfate, thiosulfate and iodide by choroid plexus in vitro. J. Neurochem. 15, 1169–1179 (1968).

    Google Scholar 

  • Roth, W.: The effect of LSD, mescaline and d-amphetamine on the evoked “secondary discharge”. Psychopharmacologia (Berl.) 9, 253–258 (1966).

    Google Scholar 

  • Rothlin, E.: Lysergic acid diethylamide and related substances. Ann. N.Y. Acad. Sci. 66, 668–676 (1957).

    Google Scholar 

  • Speck, L.: Toxicity and effects of increasing doses of mescaline. J. Pharmacol. exp. Ther. 119, 78–84 (1957).

    Google Scholar 

  • Wolbach, A., Isbell, H., Miner, E.: Cross tolerance between mescaline and LSD-25 with a comparison of the mescaline and LSD reactions. Psychopharmacologia (Berl.) 3, 1–14 (1962).

    Google Scholar 

  • Winter, J.: Behavioral effects of N,N-diethyltryptamine: Absence of antagonism by xylamidine tosylate. J. Pharmacol. exp. Ther. 169, 7–16 (1969).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Supported in part by a Grant from the USPHS-MH-08565. H.A.T. is a predoctoral fellow in the Department of Psychology, University of Minnesota

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tilson, H.A., Sparber, S.B. Differences in tolerance to mescaline produced by peripheral and direct central administration. Psychopharmacologia 19, 313–323 (1971). https://doi.org/10.1007/BF00404375

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00404375

Key-Words

Navigation